Baidu
map

2022 ESC/EHRA/AACA/APHRS意见书:房颤和静脉血栓栓塞出血风险的评估和缓解

2022-03-22 欧洲心脏病学会 Europace

2022年3月,欧洲心脏病学会(ESC)血栓形成工作组联合欧洲心律学会(EHRA)等多家学会共同发布了房颤和静脉血栓栓塞出血风险的评估缓解意见书。虽然口服抗凝药(OAC)对于房颤和静脉血栓栓塞(VTE

中文标题:

2022 ESC/EHRA/AACA/APHRS意见书:房颤和静脉血栓栓塞出血风险的评估和缓解

英文标题:

Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis

发布机构:

欧洲心脏病学会

发布日期:

2022-03-22

简要介绍:

2022年3月,欧洲心脏病学会(ESC)血栓形成工作组联合欧洲心律学会(EHRA)等多家学会共同发布了房颤和静脉血栓栓塞出血风险的评估缓解意见书。虽然口服抗凝药(OAC)对于房颤和静脉血栓栓塞(VTE)患者在降低血栓栓塞风险方面有明显临床获益,但仍可能发生重大出血事件(尤其是颅内出血),具有致命性。本文主要针对房颤和静脉血栓栓塞出血风险的评估和缓解提供共识声明。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 ESC_EHRA_AACA_APHRS意见书:房颤和静脉血栓栓塞出血风险的评估和缓解.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1f0651c002393e99, title=2022 ESC/EHRA/AACA/APHRS意见书:房颤和静脉血栓栓塞出血风险的评估和缓解, enTitle=Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, guiderFrom=Europace, authorId=0, author=, summary=2022年3月,欧洲心脏病学会(ESC)血栓形成工作组联合欧洲心律学会(EHRA)等多家学会共同发布了房颤和静脉血栓栓塞出血风险的评估缓解意见书。虽然口服抗凝药(OAC)对于房颤和静脉血栓栓塞(VTE, cover=https://img.medsci.cn/2022325/1648211851503_1608702.png, journalId=0, articlesId=null, associationId=62, associationName=欧洲心脏病学会, associationIntro=是目前在欧洲居于首要地位的心脏病学会,会员超过70000人、提供更新指南、调查数据、组织学术会议,ESC年会是心血管领域最大的会议。下设5个分会(超声心动图学会、心律学会、心衰学会、预防与康复学会及介入学会)。提供指南较全面,按年份排列。现提供有手机板本。, copyright=0, guiderPublishedTime=Tue Mar 22 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年3月,欧洲心脏病学会(ESC)血栓形成工作组联合欧洲心律学会(EHRA)等多家学会共同发布了房颤和静脉血栓栓塞出血风险的评估缓解意见书。虽然口服抗凝药(OAC)对于房颤和静脉血栓栓塞(VTE)患者在降低血栓栓塞风险方面有明显临床获益,但仍可能发生重大出血事件(尤其是颅内出血),具有致命性。本文主要针对房颤和静脉血栓栓塞出血风险的评估和缓解提供共识声明。</span></p>, tagList=[TagDto(tagId=364, tagName=房颤), TagDto(tagId=3164, tagName=静脉血栓栓塞)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4865, appHits=208, showAppHits=0, pcHits=594, showPcHits=4655, likes=0, shares=25, comments=2, approvalStatus=1, publishedTime=Sat Mar 26 15:35:00 CST 2022, publishedTimeString=2022-03-22, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Fri Mar 25 20:35:32 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Thu Jan 04 01:34:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 ESC_EHRA_AACA_APHRS意见书:房颤和静脉血栓栓塞出血风险的评估和缓解.pdf)])
2022 ESC_EHRA_AACA_APHRS意见书:房颤和静脉血栓栓塞出血风险的评估和缓解.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2098174, encodeId=9ddd20981e4dc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747a8170552, createdName=ms3000000766868070, createdTime=Thu Nov 03 09:22:54 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206389, encodeId=b7bb1206389c9, content=dd, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211016/399b012e115a4068af39569b4e0293bf/e037eaf8238a4b04a97cc89aff582179.jpg, createdBy=68785617972, createdName=ms2000000178642872, createdTime=Sun Mar 27 16:15:49 CST 2022, time=2022-03-27, status=1, ipAttribution=)]
    2022-11-03 ms3000000766868070

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2098174, encodeId=9ddd20981e4dc, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747a8170552, createdName=ms3000000766868070, createdTime=Thu Nov 03 09:22:54 CST 2022, time=2022-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1206389, encodeId=b7bb1206389c9, content=dd, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211016/399b012e115a4068af39569b4e0293bf/e037eaf8238a4b04a97cc89aff582179.jpg, createdBy=68785617972, createdName=ms2000000178642872, createdTime=Sun Mar 27 16:15:49 CST 2022, time=2022-03-27, status=1, ipAttribution=)]
    2022-03-27 ms2000000178642872

    dd

    0

Baidu
map
Baidu
map
Baidu
map